Dr. Tan is one of the rising stars in the field of nanobiomechanics. He is the co-inventor for the Circulating Tumour Cell (CTC) Microfiltration BioChip – an innovative device which allows clinicians to isolate and enumerate circulating tumour cells from whole patient blood and, most impressively, retrieve wholly intact, viable circulating tumour cells. Dr. Tan is currently the Technical Advisor of Clearbridge Biomedics and the Technical Director of Clearbridge Accelerator.
Dr. Tan is a recipient of the A*STAR Graduate Scholarship which is awarded only to the top graduates in the fields of Biomedical Sciences, Physical Sciences and Engineering. He has also won several awards, including the Young Investigator Award at the 6th World Congress on Biomechanics and the prestigious Tan Kah Kee Young Inventors’ Award.
The author/co-author of several scientific publications, Dr. Tan has been invited to present his work at both local and international conferences, such as the International Conference on Biocomputation, Bioinformatics, and Biomedical Technologies and also at the prestigious National Institutes of Health (NIH), USA.
Dr. Tan holds a B.Eng (First Class Honours) and his PhD from the National University of Singapore.
22-23 AUGUST 2017 | SEOUL, S.KOREA | PRESENTATION & BOOTH #3Learn More
NewsGenomeWeb Feature: John Wayne Cancer Institute and Clearbridge BioMedics announce partnership to develop CTC CoRE in the U.S. PR Newswire: John Wayne Cancer Institute, and Clearbridge BioMedics announce partnership to develop Circulating Tumor Cell Centre of Research Excellence in the U.S. BioSpectrum: John Wayne Cancer Institute and Clearbridge BioMedics announce partnership
22-23 AUGUST 2017 | SEOUL, S.KOREA | PRESENTATION & BOOTH #3Read more